{"entity":{"type":"insider","cik":"0001631682","url":"/insider/0001631682","json_url":"/insider/0001631682.json","name":"Hanlon Suzanne M.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":2,"first":"2016-08-17","last":"2018-08-07","span_basis":"filed_date"},"name_variants":[{"name":"Hanlon Suzanne M.","source":"filing","n_filings":2,"first_seen":"2016-08-17","last_seen":"2018-08-07"}],"transactions":[{"id":6096255,"accession":"0001192482-18-000385","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-18-000385","line_url":"/filing/0001192482-18-000385#line-1","is_derivative":false,"issuer_cik":"0001621443","issuer_name":"Zynerba Pharmaceuticals, Inc.","issuer_ticker":"ZYNE","issuer_name_source":null,"issuer_url":"/issuer/0001621443","owner_cik":"0001631682","owner_name":"Hanlon Suzanne M.","owner_url":"/insider/0001631682","role":"Officer (Sec, VP & General Counsel)","officer_title":"Sec, VP & General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3800.0,"shares_display":"3,800","price_per_share":5.802,"price_display":"5.80","price_state":"stated","total_value":22047.6,"total_display":"22,047.60","shares_owned_after":43693.0,"shares_owned_after_display":"43,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-06","filed_date":"2018-08-07","scope":"insider"},{"id":2952648,"accession":"0001123292-16-002600","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001123292-16-002600","line_url":"/filing/0001123292-16-002600#line-2","is_derivative":false,"issuer_cik":"0001621443","issuer_name":"Zynerba Pharmaceuticals, Inc.","issuer_ticker":"ZYNE","issuer_name_source":null,"issuer_url":"/issuer/0001621443","owner_cik":"0001631682","owner_name":"Hanlon Suzanne M.","owner_url":"/insider/0001631682","role":"Officer (Sec, General Counsel & VP HR)","officer_title":"Sec, General Counsel & VP HR","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":10.53,"price_display":"10.53","price_state":"stated","total_value":31590.0,"total_display":"31,590.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-16","filed_date":"2016-08-17","scope":"insider"},{"id":2952643,"accession":"0001123292-16-002600","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-16-002600","line_url":"/filing/0001123292-16-002600#line-1","is_derivative":false,"issuer_cik":"0001621443","issuer_name":"Zynerba Pharmaceuticals, Inc.","issuer_ticker":"ZYNE","issuer_name_source":null,"issuer_url":"/issuer/0001621443","owner_cik":"0001631682","owner_name":"Hanlon Suzanne M.","owner_url":"/insider/0001631682","role":"Officer (Sec, General Counsel & VP HR)","officer_title":"Sec, General Counsel & VP HR","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":17.92,"price_display":"17.92","price_state":"stated","total_value":53760.0,"total_display":"53,760.00","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-05","filed_date":"2016-08-17","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001621443","name":"Zynerba Pharmaceuticals, Inc.","url":"/issuer/0001621443","role":"Officer (Sec, VP & General Counsel)","n_filings":2,"first_seen":"2016-08-17","last_seen":"2018-08-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001631682","retrieved_at":"2026-08-21T03:36:51+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}